OLD Point Trust & Financial Services N A Sells 365 Shares of Agilent Technologies, Inc. (NYSE:A)

OLD Point Trust & Financial Services N A reduced its position in shares of Agilent Technologies, Inc. (NYSE:A) by 4.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,051 shares of the medical research company’s stock after selling 365 shares during the period. OLD Point Trust & Financial Services N A’s holdings in Agilent Technologies were worth $947,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. CKW Financial Group increased its holdings in Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 100 shares during the period. Global X Japan Co. Ltd. grew its position in shares of Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after buying an additional 116 shares during the last quarter. RPg Family Wealth Advisory LLC bought a new stake in shares of Agilent Technologies in the 3rd quarter valued at about $38,000. Hanson & Doremus Investment Management increased its stake in shares of Agilent Technologies by 66.5% in the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock valued at $35,000 after buying an additional 105 shares during the period. Finally, OFI Invest Asset Management bought a new position in shares of Agilent Technologies during the fourth quarter worth about $37,000.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. The trade was a 4.60 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of the company’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares of the company’s stock, valued at approximately $2,657,456.28. The trade was a 8.05 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Stock Down 0.7 %

A stock opened at $122.27 on Thursday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. Agilent Technologies, Inc. has a fifty-two week low of $117.17 and a fifty-two week high of $155.35. The stock’s 50 day simple moving average is $137.41 and its 200 day simple moving average is $137.57. The company has a market cap of $34.86 billion, a P/E ratio of 28.11, a price-to-earnings-growth ratio of 3.45 and a beta of 1.11.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. The company had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. On average, research analysts expect that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is currently 22.76%.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Sanford C. Bernstein reduced their target price on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a report on Tuesday, November 26th. Citigroup upped their price objective on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a research note on Thursday, December 19th. JPMorgan Chase & Co. lowered their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, November 26th. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research report on Monday, December 9th. Finally, Bank of America decreased their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a report on Friday, December 13th. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $146.15.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.